SAN DIEGO, April 30, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced its scheduled presentation to provide an overview of the company's programs and outlook at the Deutsche Bank 39th Annual Health Care Conference at 2:50 p.m. ET on Wednesday, May 7, 2014, in Boston.
Help employers find you! Check out all the jobs and post your resume.
